Skip to main content

Day: June 8, 2020

CloudCommerce Powers through the Pandemic

SAN ANTONIO, June 08, 2020 (GLOBE NEWSWIRE) — CloudCommerce, Inc. (CLWD), a leading provider of digital advertising solutions, today announced that in spite of the economic downturn caused by the COVID-19 pandemic, the Company has recently increased revenue from its existing client base and added new clients within the past few weeks.“As was the case with most business leaders, our management team was concerned about the economic headwinds caused by the COVID-19 pandemic,” said Andrew Van Noy, CEO of CloudCommerce. “However, I am pleased to announce that our recent sales efforts have resulted in newfound revenue growth for CloudCommerce. As the economy begins to re-open, we are also seeing existing clients ramp up their digital advertising budgets. The strong trend to digital media and away from traditional media appears to be accelerating...

Continue reading

Exercise of warrants in Better Collective A/S; Board of Directors issues 12,690 new ordinary shares

Regulatory release no. 28/2020In the exercise window which opened on May 15, 2020 following Better Collective’s Q1 report and closed on May 29,  2020, 3 employees have informed the company that they wish  to exercise in total 12,690 warrants under the 2017 warrant program.The 2017 warrant program was established prior to the company’s IPO and the warrants were issued in 2017 and 2018. Reference is made to schedule 2 of the company’s articles of association for detailed terms of conditions of the warrants.As of 29 May 2020, 889,114 warrants remain outstanding (excluding the warrants exercised following the Q1 report) under the 2017 warrant program, all with rights to subscribe for 1 ordinary share in Better Collective A/S against payment of an exercise price of DKK 12.962962 per warrant.Today Better Collective’s board of directors resolved...

Continue reading

Valoe Corporation’s Share Subscription Based on Convertible Bond 4/2019

Valoe Corporation                                              Stock Exchange Release 8 June 2020 at 09.10 (Finnish time)The Board of Directors of Valoe Corporation (the “Company”) has resolved on the share subscription based on the conversion of the promissory notes issued under the Company’s convertible bond 4/2019. In the said share subscription, the lender of the convertible bond 4/2019 subscribed in total 1,155,921 new shares (the “New Shares”) in the Company by converting the promissory notes into the New Shares pursuant to the conversion request delivered to the Company (the “Share Subscription”).The terms of the convertible bond 4/2019 were disclosed as stock exchange release on 5 November 2019. One loan share of EUR 100,000 pursuant to the promissory note entitled the lender to subscribe...

Continue reading

Valoe Oyj:n osakkeiden merkintä vaihtovelkakirjalaina 4/2019 lainaosuuksia vaihtamalla

Valoe Oyj                            Pörssitiedote                                                     8.6.2020 klo 09.10Valoe Oyj:n (“Yhtiö”) hallitus on tänään päättänyt Yhtiön vaihtovelkakirjalainaan 4/2019 perustuvasta vaihtovelkakirjalainan osuuksien vaihtamisella tapahtuvasta Yhtiön uusien osakkeiden merkinnästä, jossa vaihtovelkakirjalainan haltija merkitsee Yhtiölle esitetyn vaihtovaatimuksen perusteella yhteensä 1.155.921 Yhtiön uutta osaketta (“Uudet Osakkeet”) vaihtovelkakirjalainaosuuksia vaihtamalla (“Osakemerkintä”).Vaihtovelkakirjalainan 4/2019 ehdot on julkistettu pörssitiedotteella 5.11.2019.  Vaihtovelkakirjan mukainen yksi 100.000 euron lainaosuus oikeutti sen vaihtajan merkitsemään yhteensä 1.111.111 Yhtiön uutta osaketta. Merkintähinta per Uusi Osake oli Vaihtovelkakirjalainan 4/2019...

Continue reading

Global Care Capital Inc Closes Acquisition of 70% Interest in High Standard Health Care Generating $4 Million with 40% Gross Margin in Orders to Date

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, June 08, 2020 (GLOBE NEWSWIRE) — Global Care Capital Inc. (CSE:HLTH, FRANKFURT: L6V1) (the “Company” or “Global Care”) a global investment company which engages in early stage investment opportunities in private and public companies, is pleased to announce that further to its press release of June 3rd, 2020, the Company has acquired 70% of the issued and outstanding common shares of High Standard Health Care Ltd. (“High Standard Health Care”), a portfolio company founded by Dan Kriznic at High Standard Capital Corp., in exchange for securities of Global Care, (the “Transaction”).High Standard Health Care specializes in procuring personal protective equipment (“PPE”) including but not limited to respiratory...

Continue reading

ROYAL DUTCH SHELL PLC FIRST QUARTER 2020 EURO AND GBP EQUIVALENT DIVIDEND PAYMENT

The Hague, June 8, 2020 – The Board of Royal Dutch Shell plc (“RDS”) today announced the pounds sterling and euro equivalent dividend payments in respect of the first quarter 2020 interim dividend, which was announced on April 30, 2020 at US$0.16 per A ordinary share (“A Share”) and B ordinary share (“B Share”).Dividends on B Shares will be paid, by default, in pounds sterling at the rate of 12.68p per B Share. Holders of B Shares who have validly submitted US dollars or euros currency elections by June 2, 2020 will be entitled to a dividend of US$0.16 or €0.1420 per B Share, respectively.Euro and pounds sterling dividends payable in cash have been converted from US dollars based on an average of market exchange rates over the three dealing days from 3 to 5 June 2020.This dividend will be payable on June 22, 2020 to those members...

Continue reading

Notifications on the transactions concluded by manager in issuer’s securities

Šiaulių Bankas AB, company code 112025254, address of the head office Tilžės str. 149, Šiauliai, Lithuania.Šiaulių bankas AB has received the notifications of the person, closely associated with the manager, on transactions in securities issued by the bank (attached). Director of Securities Accounting Department Jolanta Dobiliauskienė is authorized by the Issuer to provide additional information and is available on tel.: +370 41 595669.AttachmentsINVL Extremo 3_20200605_enINVL Medio 3_20200605_enINVL Pensija 1975-1981_20200605_enINVL Pensija 1968-1974_20200605_enINVL Pensija 1982-1988_20200605_enINVL Pensija 1989-1995_20200605_enINVL Pensija 1996-2002_20200605_en

Continue reading

Pranešimai apie vadovo sandorius dėl Emitento vertybinių popierių

AB Šiaulių bankas, įmonės kodas 112025254, buveinės adresas: Tilžės g. 149, Šiauliai, Lietuva.AB Šiaulių bankas gavo su vadovu glaudžiai susijusio asmens pranešimus apie sandorius dėl banko išleistų vertybinių popierių (pridedama).Emitento įgaliotas teikti papildomą informaciją – VP apskaitos departamento direktorė Jolanta Dobiliauskienė, tel. (8 41) 595 669.PriedaiINVL Medio III_20200605_ltINVL_Extremo III_20200605_ltINVL Pensija 1968-1974_20200605_ltINVL Pensija 1975-1981_20200605_ltINVL Pensija 1982-1988_20200605_ltINVL Pensija 1989-1995_20200605_ltINVL Pensija 1996-2002_20200605_lt

Continue reading

CNH Industrial announces updates on its investment in Nikola Corporation

London, June 8, 2020CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) today announced the following updates on the $250 million  investment, made through its IVECO commercial vehicle segment, in Nikola Corporation (NASDAQ: NKLA) as a consequence of the completion, on June 3, 2020, of the previously announced merger between VectoIQ Acquisition Corp., a publicly-traded special purpose acquisition company, and Nikola Corporation (the ‘Merger’).Under the terms and conditions of the Merger, the former shareholders of Nikola received 1.901 shares of VectoIQ for every one share held in Nikola and became shareholders of VectoIQ, which, in turn, changed its name to “Nikola Corporation”. Nikola Corporation shares began trading on Nasdaq under the new ticker symbol “NKLA” on June 4, 2020.As a result of the Merger, IVECO now holds 25,661,449 shares of...

Continue reading

US FDA Grants Mexiletine Orphan Drug Designation

US FDA Grants Mexiletine Orphan Drug DesignationZug, Switzerland, 8 June 2019: Lupin is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to mexiletine hydrochloride for the treatment of myotonic disorders.Myotonic disorders are a group of heterogeneous, inherited, neuromuscular disorders characterized by a shared symptom called myotonia. Myotonia is an inability to relax a contraction of skeletal muscle which originates from a voluntary muscular contraction such as shaking someone’s hand and blinking, or everyday activities such as walking across a street and climbing stairs. Mexiletine reduces myotonia symptoms, resulting in a significant improvement in patient quality-of-life and other functional outcomes1.The FDA grants ODD status to medicines intended for the treatment, diagnosis...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.